| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.21 |
5e-06 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |